S&P 500   4,276.69 (-1.40%)
DOW   33,602.53 (-1.19%)
QQQ   354.32 (-1.47%)
AAPL   172.57 (-1.99%)
MSFT   311.39 (-1.94%)
META   298.76 (-0.69%)
GOOGL   128.24 (-2.19%)
AMZN   126.47 (-3.66%)
TSLA   243.13 (-1.56%)
NVDA   421.68 (-0.13%)
NIO   8.43 (+0.96%)
BABA   85.85 (-1.57%)
AMD   95.67 (-1.76%)
T   15.04 (-0.13%)
F   12.39 (-1.51%)
MU   67.93 (-0.95%)
CGC   0.89 (-5.14%)
GE   110.03 (-1.51%)
DIS   79.93 (-1.33%)
AMC   7.92 (-2.70%)
PFE   32.51 (-1.43%)
PYPL   58.66 (-0.34%)
NFLX   378.08 (-1.75%)
S&P 500   4,276.69 (-1.40%)
DOW   33,602.53 (-1.19%)
QQQ   354.32 (-1.47%)
AAPL   172.57 (-1.99%)
MSFT   311.39 (-1.94%)
META   298.76 (-0.69%)
GOOGL   128.24 (-2.19%)
AMZN   126.47 (-3.66%)
TSLA   243.13 (-1.56%)
NVDA   421.68 (-0.13%)
NIO   8.43 (+0.96%)
BABA   85.85 (-1.57%)
AMD   95.67 (-1.76%)
T   15.04 (-0.13%)
F   12.39 (-1.51%)
MU   67.93 (-0.95%)
CGC   0.89 (-5.14%)
GE   110.03 (-1.51%)
DIS   79.93 (-1.33%)
AMC   7.92 (-2.70%)
PFE   32.51 (-1.43%)
PYPL   58.66 (-0.34%)
NFLX   378.08 (-1.75%)
S&P 500   4,276.69 (-1.40%)
DOW   33,602.53 (-1.19%)
QQQ   354.32 (-1.47%)
AAPL   172.57 (-1.99%)
MSFT   311.39 (-1.94%)
META   298.76 (-0.69%)
GOOGL   128.24 (-2.19%)
AMZN   126.47 (-3.66%)
TSLA   243.13 (-1.56%)
NVDA   421.68 (-0.13%)
NIO   8.43 (+0.96%)
BABA   85.85 (-1.57%)
AMD   95.67 (-1.76%)
T   15.04 (-0.13%)
F   12.39 (-1.51%)
MU   67.93 (-0.95%)
CGC   0.89 (-5.14%)
GE   110.03 (-1.51%)
DIS   79.93 (-1.33%)
AMC   7.92 (-2.70%)
PFE   32.51 (-1.43%)
PYPL   58.66 (-0.34%)
NFLX   378.08 (-1.75%)
S&P 500   4,276.69 (-1.40%)
DOW   33,602.53 (-1.19%)
QQQ   354.32 (-1.47%)
AAPL   172.57 (-1.99%)
MSFT   311.39 (-1.94%)
META   298.76 (-0.69%)
GOOGL   128.24 (-2.19%)
AMZN   126.47 (-3.66%)
TSLA   243.13 (-1.56%)
NVDA   421.68 (-0.13%)
NIO   8.43 (+0.96%)
BABA   85.85 (-1.57%)
AMD   95.67 (-1.76%)
T   15.04 (-0.13%)
F   12.39 (-1.51%)
MU   67.93 (-0.95%)
CGC   0.89 (-5.14%)
GE   110.03 (-1.51%)
DIS   79.93 (-1.33%)
AMC   7.92 (-2.70%)
PFE   32.51 (-1.43%)
PYPL   58.66 (-0.34%)
NFLX   378.08 (-1.75%)
CVE:SBM

Sirona Biochem (SBM) Stock Forecast, Price & News

C$0.10
-0.01 (-9.52%)
(As of 10:30 AM ET)
Compare
Today's Range
C$0.10
▼
C$0.10
50-Day Range
C$0.10
▼
C$0.12
52-Week Range
C$0.08
▼
C$0.22
Volume
600 shs
Average Volume
60,827 shs
Market Capitalization
C$23.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlines

SBM stock logo

About Sirona Biochem (CVE:SBM) Stock

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

SBM Price History

SBM Stock News Headlines

September 23, 2023 | americanbankingnews.com
Sirona Biochem (CVE:SBM) Stock Price Up 4.8%
August 22, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp up on Monday (SBM)
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
June 28, 2023 | finanznachrichten.de
Sirona Biochem Corp.: Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
June 28, 2023 | finance.yahoo.com
Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
May 25, 2023 | stockhouse.com
Sirona Biochem Engages Atheln Inc. to Strengthen Business Development Initiatives
May 11, 2023 | finance.yahoo.com
Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy
May 10, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp down on Tuesday (SBM)
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
May 6, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp down on Wednesday (SBM)
May 4, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp up on Wednesday (SBM)
May 3, 2023 | finance.yahoo.com
Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston
May 2, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp down on Monday (SBM)
April 25, 2023 | finance.yahoo.com
Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326
April 25, 2023 | proactiveinvestors.com
Sirona Biochem stock climbs on anti-aging compound clinical trial results
April 22, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp up on Friday (SBM)
April 21, 2023 | finanznachrichten.de
Sirona Biochem Corp.: Sirona Biochem Announces Close of Oversubscribed Debenture Financing
April 20, 2023 | finance.yahoo.com
Sirona Biochem Announces Close of Oversubscribed Debenture Financing
April 13, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp flat on Wednesday (SBM)
April 8, 2023 | theglobeandmail.com
Closing Bell: Sirona Biochem Corp flat on Thursday (SBM)
March 23, 2023 | finanznachrichten.de
Sirona Biochem Corp.: Sirona Biochem Announces Debenture Financing
March 23, 2023 | finance.yahoo.com
Sirona Biochem Announces Debenture Financing
March 19, 2023 | benzinga.com
Enzo Biochem shares are trading higher after the company announced it will sell its clinical laboratory to Labcorp.
March 1, 2023 | finance.yahoo.com
Sirona Biochem Receives Antiviral Testing Results
February 6, 2023 | technews.tmcnet.com
William R. Brody, MD, PhD joins Sirona Medical's Board of Directors to help accelerate radiology's IT transformation.
January 16, 2023 | finanznachrichten.de
Sirona Biochem Corp.: Sirona Biochem Announces the Termination of Supply Agreement with Rodan + Fields
December 31, 2022 | finanznachrichten.de
Sirona Biochem Corp.: Sirona Biochem Announces 2022 Annual Meeting Results
See More Headlines
Receive SBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:SBM
CUSIP
N/A
CIK
N/A
Web
www.sironabiochem.com
Phone
604-641-4466
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-2,130,000.00
Net Margins
-291.37%
Pretax Margin
N/A
Return on Equity
-9,810.47%
Return on Assets
-72.54%

Debt

Debt-to-Equity Ratio
219.21
Current Ratio
2.05
Quick Ratio
2.41

Sales & Book Value

Annual Sales
C$683,768.00
Price / Sales
35.03
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
252,110,000
Free Float
N/A
Market Cap
C$23.95 million
Optionable
Not Optionable
Beta
-0.27
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Howard J. Verrico M.D. (Age 62)
    Ph.D., Founder, Chairman, CEO & Sec.
    Comp: $161.28k
  • Mr. Christopher D. Hopton C.G.A. (Age 57)
    C.P.A., CFO & Director
    Comp: $147.84k
  • Dr. Géraldine Deliencourt-Godefroy Ph.D.
    Chief Scientific Officer & Director

Key Competitors

View All Competitors













SBM Stock - Frequently Asked Questions

How have SBM shares performed in 2023?

Sirona Biochem's stock was trading at C$0.12 at the start of the year. Since then, SBM stock has decreased by 17.4% and is now trading at C$0.10.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Sirona Biochem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP).

What is Sirona Biochem's stock symbol?

Sirona Biochem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SBM."

How do I buy shares of Sirona Biochem?

Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Sirona Biochem's stock price today?

One share of SBM stock can currently be purchased for approximately C$0.10.

How much money does Sirona Biochem make?

Sirona Biochem (CVE:SBM) has a market capitalization of C$23.95 million and generates C$683,768.00 in revenue each year. The company earns C$-2,130,000.00 in net income (profit) each year or C($0.01) on an earnings per share basis.

How can I contact Sirona Biochem?

Sirona Biochem's mailing address is 595 Burrard Street, Vancouver, BC V7X 1L4, Canada, . The official website for the company is www.sironabiochem.com. The company can be reached via phone at 604-641-4466.

This page (CVE:SBM) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -